期刊文献+

HIV耐药检测的临床应用 被引量:4

Clinical application of HIV drug resistance testing
下载PDF
导出
摘要 检测HIV耐药毒株可采用基因型和表型方法。由于HIV及其准种的高度变异性、抗HIV药物种类及其作用机制的多样性及HIV耐药检测方法的复杂性,目前,熟练运用HIV耐药检测方法并将检测结果整合到临床常规治疗的管理还存在很大问题,制订合理的临床应用指南是耐药检测面临的最大挑战。本文针对常用的2种HIV耐药检测方法,分析解释检测结果使用的方法及存在的问题,介绍国际最新的HIV耐药检测临床使用规范,并提出未来HIV耐药检测及临床应用应关注和解决的问题。 Genotype and phenotype testing can be used for HIV drug resistance testing. Because of the high diversity of HIV and its quasispecies, the variety of antiretroviral drugs and its mechanism and the complexity of HIV drug resistance testing, skillful use of the drug resistance testing and integration of the testing results into clinical management remains a big problem, and working out the rational clinical application guideline is a rigorous challenge for HIV drug resistance testing. In this paper, the author inter- prets and analyzes the results of genotype and phenotype testing and the exsiting problems, introduces the updated international clinical specifications of HIV drug resistance testing, and puts forward the problems to be focused on and be resolved in the future in the field of HIV drug resistance testing and its clinical application.
作者 李敬云
出处 《传染病信息》 2012年第6期325-327,338,共4页 Infectious Disease Information
基金 国家自然科学基金重点项目(30830088)
关键词 HIV 药物耐受性 基因型分型技术 HIV drug tolerance genotyping techniques
  • 相关文献

参考文献13

  • 1AIDSinfo. Offering information on HIV/AID treatmmt, prevention and researchl EB/OL]. [ 2012-09-05 ]. http://aidsinfo.nih.gov/drugs.
  • 2Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 in- fection with early antiretroviral therapy[J]. N Engl J Med, 2011, 365(6):493-505.
  • 3Thompson MA, Aberg JA, Hoy JF, et ol. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA Panel[J]. JAMA, 2012, 308(4):387-402.
  • 4U.S. Food and Drug Administration. Truvada approved to reduce the risk of sexually transmitted HIV in people who are not infected with the virus[EB/OL]. [2012-09-01]. http://www.fda.gov/For- Consumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivi -ties/ucm312264.htm.
  • 5Larder BA, Darby G, Richman DD. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy [J]. Science, 1989, 243(4899):1731-1734.
  • 6Larder BA, Kemp SD. Multiple mutations in HIV-1 reverse tran- scriptase confer high-level resistance to zidovudine(AZT)[J]. Sci- ence, 1989, 246(4934): 1155-1158.
  • 7Vandamme AM, Camacho ILl, Ceccherini-Silberstein F, et al. Eu- ropean recommendations for the clinical use of HIV drug resis- tance testing: 2011 update[J]. AIDS Rev, 2011, 13(2):77-108.
  • 8Gianotti N, Mondino V, Rossi MC, et al. Comparison of a rule- based algorithm with a phenotype-based algorithm for the inter- pretation of HIV genotypes in guiding salvage regimens in H1V- infected patients by a randomized clinical trial: the mutations and salvage study[J]. Clin Infect Dis, 2006, 42(10):1470-1480.
  • 9Hirsch MS, Conway B, D'Aquila RT, et ol. Antiretroviral drug re- sistance testing in adults with HIV infection: implications for clinical management. International AIDS Society-USA Panel[J]. JAMA, 1998, 279(24):1984-1991.
  • 10AIDSinfo. Guidelines for the use of antiretroviral agents in HIV-1- infected adults and adolescents [ EB/OL ]. [ 2012-09-05 ]. http: //aidsinfo.nih.gov/contentfiles/AduhandAdolescentGL001419.pdf.

同被引文献28

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部